Home › Funds › FundVantage Trust › Polen 5Perspectives Small Growth Fund
Fund family: FundVantage Trust · Filed by FundVantage Trust (CIK 1388485) · SEC series S000059535
Share classes and tickers: PBSIX (C000194993), PBSRX (C000194994), PBSYX (C000227429)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 605 with, 0 against, 0 abstentions (not counted as with management); 5 items carried no recommendation. Shareholder proposals: 0 FOR, 0 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as FundVantage Trust’s manager page (34,297 ballot items across 20 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | FundVantage Trust | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 96.4% | 580 | 94.4% | 31,140 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 11.9% | 714 |
Each ballot item this fund voted is set against the votes of the other FundVantage Trust funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most FundVantage Trust funds on 18 items (12.2% of the 147 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most FundVantage Trust funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Clear Secure, Inc. | 2026-06-10 | Approval of, on an advisory basis, the compensation of our named executive officers. | For | AGAINST — 3 of 3 FundVantage Trust funds | For | Approved, 95.4% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Andrew T. D'Amico | For | WITHHOLD — 3 of 3 FundVantage Trust funds | For | Passed (calculated), 94.3% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Claudio Tuozzolo | For | WITHHOLD — 3 of 3 FundVantage Trust funds | For | Passed (calculated), 94.3% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Estia J. Eichten | For | WITHHOLD — 3 of 3 FundVantage Trust funds | For | Passed (calculated), 91.7% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: James F. Schmidt | For | WITHHOLD — 3 of 3 FundVantage Trust funds | For | Passed (calculated), 94.1% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Jason L. Carlson | For | WITHHOLD — 3 of 3 FundVantage Trust funds | For | Passed (calculated), 93.7% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: John Shen | For | WITHHOLD — 3 of 3 FundVantage Trust funds | For | Passed (calculated), 94.7% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Michael S. McNamara | For | WITHHOLD — 3 of 3 FundVantage Trust funds | For | Passed (calculated), 94.3% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Patrizio Vinciarelli | For | WITHHOLD — 3 of 3 FundVantage Trust funds | For | Passed (calculated), 94.0% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Philip D. Davies | For | WITHHOLD — 3 of 3 FundVantage Trust funds | For | Passed (calculated), 94.5% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Samuel J. Anderson | For | WITHHOLD — 3 of 3 FundVantage Trust funds | For | Passed (calculated), 94.4% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Zmira Lavie | For | WITHHOLD — 3 of 3 FundVantage Trust funds | For | Passed (calculated), 94.7% support |
| Adaptive Biotechnologies Corporation | 2026-06-05 | To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders: Robert Hershberg, PhD, MD | For | WITHHOLD — 3 of 3 FundVantage Trust funds | For | — |
| Peloton Interactive, Inc. | 2025-12-09 | Election of Directors: Chris Bruzzo | For | WITHHOLD — 3 of 3 FundVantage Trust funds | For | Elected, 77.8% support |
| nLIGHT, Inc. | 2026-06-05 | Election of Class II Director: Geoffrey Moore | For | WITHHOLD — 3 of 3 FundVantage Trust funds | For | Passed (calculated), 55.6% support |
| nLIGHT, Inc. | 2026-06-05 | To approve, on an advisory, non-binding basis, the compensation of our named executive officers. | For | AGAINST — 3 of 3 FundVantage Trust funds | For | Not approved, 39.1% support |
| Amprius Technologies, Inc. | 2026-06-11 | Election of Class I Directors: Kathleen Bayless | For | WITHHOLD — 3 of 3 FundVantage Trust funds | For | Elected, 71.4% support |
| Amprius Technologies, Inc. | 2026-06-11 | Election of Class I Directors: Thomas M. Stepien | For | WITHHOLD — 3 of 3 FundVantage Trust funds | For | Elected, 76.4% support |
Download all 18 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 87.1% of this fund’s 605 such votes could be given a sector; the other 78 (12.9%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 123 | 0 | 0.0% |
| Industrials | 111 | 0 | 0.0% |
| Health Care | 109 | 0 | 0.0% |
| Technology | 79 | 0 | 0.0% |
| Finance | 54 | 0 | 0.0% |
| Energy | 24 | 0 | 0.0% |
| Real Estate | 24 | 0 | 0.0% |
| Miscellaneous | 3 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 399 | 0 |
| Say-on-Pay | 73 | 0 |
| Audit-related | 72 | 0 |
| Compensation | 27 | 0 |
| Corporate Governance | 26 | 0 |
| Capital Structure | 12 | 0 |
| Extraordinary Transactions | 4 | 0 |
| Other | 3 | 0 |
| Shareholder Rights and Defenses | 1 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Bloom Energy Corporation | May 21, 2026 | $2M | 8 | 0 |
| DigitalOcean Holdings, Inc. | June 15, 2026 | $2M | 4 | 0 |
| VSE Corporation | May 7, 2026 | $1M | 11 | 0 |
| Clear Secure, Inc. | June 10, 2026 | $1M | 13 | 0 |
| Victory Capital Holdings, Inc. | May 6, 2026 | $1M | 5 | 0 |
| Sphere Entertainment Co. | June 10, 2026 | $1M | 7 | 0 |
| Solaris Energy Infrastructure, Inc. | May 15, 2026 | $1M | 5 | 0 |
| Guardant Health, Inc. | June 17, 2026 | $1M | 5 | 0 |
617 ballot items at 79 meetings in 2025-2026. Download all votes (CSV)
In the 2025-2026 proxy season, Polen 5Perspectives Small Growth Fund (PBSIX) voted at 79 shareholder meetings of 79 companies, on 617 ballot items in all. Where management made a recommendation, the fund followed it on 100.0% of the items and voted against it 0 times. It voted FOR the board's own proposals more often than FundVantage Trust's funds as a whole (96.4% against 94.4%). It voted differently from most FundVantage Trust funds on 18 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of FundVantage Trust’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.